Zobrazeno 1 - 10
of 44
pro vyhledávání: '"M Martusewicz-Boros"'
Autor:
Sebastian Majewski, Adam J. Białas, Adam Barczyk, Halina Batura-Gabryel, Małgorzata Buchczyk, Anna Doboszyńska, Katarzyna Górska, Luiza Grabowska-Skudlarz, Hanna Jagielska-Len, Agnieszka Jarzemska, Ewa Jassem, Dariusz Jastrzębski, Aleksander Kania, Marek Koprowski, Michał Krawczyk, Rafał Krenke, Katarzyna Lewandowska, Barbara Mackiewicz, Magdalena M. Martusewicz-Boros, Janusz Milanowski, Małgorzata Noceń-Piskorowska, Agata Nowicka, Kazimierz Roszkowski-Śliż, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Tomasz Stachura, Małgorzata Tomczak, Witold Tomkowski, Marzena Trzaska-Sobczak, Dariusz Ziora, Beata Żołnowska, Wojciech J. Piotrowski
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 14, p 4635 (2023)
Nintedanib is a disease-modifying agent licensed for the treatment of IPF. Data on Polish experience with nintedanib in IPF are lacking. The present study aimed to describe the safety and efficacy profiles of nintedanib in a large real-world cohort o
Externí odkaz:
https://doaj.org/article/d2097fe1367643529ed87eaa586a7108
Autor:
Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem, Aleksander Kania, Katarzyna Lewandowska, Sebastian Majewski, Magdalena M. Martusewicz-Boros, Wojciech J. Piotrowski, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Marzena Trzaska-Sobczak, Witold Tomkowski, Beata Żołnowska, Rafał Krenke
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Pirfenidone and nintedanib are considered as the standard of care in idiopathic pulmonary fibrosis (IPF), but there is no consensus as to which of these two agents should be regarded as first-line treatment. Objective: To provide real-wor
Externí odkaz:
https://doaj.org/article/f292078d43f34b2ea0136d89cf7f4dc6
Autor:
Sebastian Majewski, Adam J. Białas, Małgorzata Buchczyk, Paweł Gomółka, Katarzyna Górska, Hanna Jagielska-Len, Agnieszka Jarzemska, Ewa Jassem, Dariusz Jastrzębski, Aleksander Kania, Marek Koprowski, Rafał Krenke, Jan Kuś, Katarzyna Lewandowska, Magdalena M. Martusewicz-Boros, Kazimierz Roszkowski-Śliż, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Karolina Szewczyk, Małgorzata Tomczak, Witold Tomkowski, Elżbieta Wiatr, Dariusz Ziora, Beata Żołnowska, Wojciech J. Piotrowski
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Pirfenidone is an antifibrotic agent approved for the treatment of idiopathic pulmonary fibrosis (IPF). The drug is available for Polish patients with IPF since 2017. The PolExPIR study aimed to describe the real-world data (RWD)
Externí odkaz:
https://doaj.org/article/819a0c653b2745e99c064475c66a7334
Publikováno v:
Polish Archives of Internal Medicine.
Publikováno v:
01.01 - Clinical problems - no related to asthma or COPD.
Publikováno v:
09.04 - Psychologists and behavioural scientists.
Publikováno v:
01.05 - Clinical respiratory physiology, exercise and functional imaging.
Autor:
K Górska, M Maskey-Warzęchowska, M Barnaś, A Białas, A Barczyk, H Jagielska-Len, E Jassem, A Kania, K Lewandowska, S Majewski, M Martusewicz-Boros, W Piotrowski, A Siemińska, K Sładek, M Sobiecka, M Trzaska-Sobczak, W Tomkowski, B Żołnowska, R Krenke
Publikováno v:
12.01 - Idiopathic interstitial pneumonias.
Autor:
Wojciech J, Piotrowski, Magdalena M, Martusewicz-Boros, Adam J, Białas, Adam, Barczyk, Bogdan, Batko, Katarzyna, Błasińska, Piotr W, Boros, Katarzyna, Górska, Piotr, Grzanka, Ewa, Jassem, Dariusz, Jastrzębski, Janina, Kaczyńska, Otylia, Kowal-Bielecka, Eugeniusz, Kucharz, Jan, Kuś, Barbara, Kuźnar-Kamińska, Brygida, Kwiatkowska, Renata, Langfort, Katarzyna, Lewandowska, Barbara, Mackiewicz, Sebastian, Majewski, Joanna, Makowska, Joanna, Miłkowska-Dymanowska, Elżbieta, Puścińska, Alicja, Siemińska, Małgorzata, Sobiecka, Renata Anna, Soroka-Dąda, Małgorzata, Szołkowska, Elżbieta, Wiatr, Dariusz, Ziora, Paweł, Śliwiński
Publikováno v:
Advances in respiratory medicine. 90(5)
The recommendations were developed as answers to previously formulated questions concerning everyday diagnostic and therapeutic challenges. They were developed based on a review of the current literature using the GRADE methodology. The experts sugge
Autor:
Magdalena M, Martusewicz-Boros, Piotr W, Boros, Elżbieta, Wiatr, Jacek, Zych, Dorota, Piotrowska-Kownacka, Kazimierz, Roszkowski-Śliż
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Cardiac sarcoidosis (CS) is a life-threatening and underdiagnosed manifestation of the disease, which requires a complicated and expensive diagnostic pathway. There is a need for simple tool
Cardiac sarcoidosis (CS) is a life-threatening and underdiagnosed manifestation of the disease, which requires a complicated and expensive diagnostic pathway. There is a need for simple tool